Salatino M - Search Results

1

Sweetening the hallmarks of cancer: Galectins as multifunctional mediators of tumor progression.

Girotti MR, Salatino M, Dalotto-Moreno T, Rabinovich GA. Girotti MR, et al. Among authors: salatino m. J Exp Med. 2020 Feb 3;217(2):e20182041. doi: 10.1084/jem.20182041. J Exp Med. 2020. PMID: 31873723 Free PMC article. Review.

2

Regulation of galectin-1 expression by transforming growth factor beta1 in metastatic mammary adenocarcinoma cells: implications for tumor-immune escape.

Daroqui CM, Ilarregui JM, Rubinstein N, Salatino M, Toscano MA, Vazquez P, Bakin A, Puricelli L, Bal de Kier Joffé E, Rabinovich GA. Daroqui CM, et al. Among authors: salatino m. Cancer Immunol Immunother. 2007 Apr;56(4):491-9. doi: 10.1007/s00262-006-0208-9. Epub 2006 Aug 10. Cancer Immunol Immunother. 2007. PMID: 16900348 Free PMC article.

3

Dissecting the pathophysiologic role of endogenous lectins: glycan-binding proteins with cytokine-like activity?

Toscano MA, Ilarregui JM, Bianco GA, Campagna L, Croci DO, Salatino M, Rabinovich GA. Toscano MA, et al. Among authors: salatino m. Cytokine Growth Factor Rev. 2007 Feb-Apr;18(1-2):57-71. doi: 10.1016/j.cytogfr.2007.01.006. Epub 2007 Feb 22. Cytokine Growth Factor Rev. 2007. PMID: 17321195 Review.

4

Galectin-1 as a potential therapeutic target in autoimmune disorders and cancer.

Salatino M, Croci DO, Bianco GA, Ilarregui JM, Toscano MA, Rabinovich GA. Salatino M, et al. Expert Opin Biol Ther. 2008 Jan;8(1):45-57. doi: 10.1517/14712598.8.1.45. Expert Opin Biol Ther. 2008. PMID: 18081536 Review.

5

Tolerogenic signals delivered by dendritic cells to T cells through a galectin-1-driven immunoregulatory circuit involving interleukin 27 and interleukin 10.

Ilarregui JM, Croci DO, Bianco GA, Toscano MA, Salatino M, Vermeulen ME, Geffner JR, Rabinovich GA. Ilarregui JM, et al. Among authors: salatino m. Nat Immunol. 2009 Sep;10(9):981-91. doi: 10.1038/ni.1772. Epub 2009 Aug 9. Nat Immunol. 2009. PMID: 19668220

6

Dissecting the signal transduction pathways triggered by galectin-glycan interactions in physiological and pathological settings.

Laderach DJ, Compagno D, Toscano MA, Croci DO, Dergan-Dylon S, Salatino M, Rabinovich GA. Laderach DJ, et al. Among authors: salatino m. IUBMB Life. 2010 Jan;62(1):1-13. doi: 10.1002/iub.281. IUBMB Life. 2010. PMID: 20014236 Free article. Review.

7

Fine-tuning antitumor responses through the control of galectin-glycan interactions: an overview.

Salatino M, Rabinovich GA. Salatino M, et al. Methods Mol Biol. 2011;677:355-74. doi: 10.1007/978-1-60761-869-0_23. Methods Mol Biol. 2011. PMID: 20941621

8

Tumor immune escape mechanisms that operate during metastasis.

Croci DO, Salatino M. Croci DO, et al. Among authors: salatino m. Curr Pharm Biotechnol. 2011 Nov;12(11):1923-36. doi: 10.2174/138920111798376987. Curr Pharm Biotechnol. 2011. PMID: 21470132 Review.

9

Cell-type specific regulation of galectin-3 expression by glucocorticoids in lung Clara cells and macrophages.

Maldonado CA, Sundblad V, Salatino M, Elia J, García LN, Leimgruber C, Croci DO, Rabinovich GA. Maldonado CA, et al. Among authors: salatino m. Histol Histopathol. 2011 Jun;26(6):747-59. doi: 10.14670/HH-26.747. Histol Histopathol. 2011. PMID: 21472689

10

The aggressiveness of murine lymphomas selected in vivo by growth rate correlates with galectin-1 expression and response to cyclophosphamide.

Zacarías Fluck MF, Hess L, Salatino M, Croci DO, Stupirski JC, Di Masso RJ, Roggero E, Rabinovich GA, Scharovsky OG. Zacarías Fluck MF, et al. Among authors: salatino m. Cancer Immunol Immunother. 2012 Apr;61(4):469-80. doi: 10.1007/s00262-011-1114-3. Epub 2011 Sep 27. Cancer Immunol Immunother. 2012. PMID: 21947259 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page